Clinical trial

SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

NCT04401904

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-06-25

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2020-06-25Date precision: day

Registry last updated2024-01-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Agingunresolved

Interventions

Dapagliflozin 10 mgDRUG · verified · RxNorm: dapagliflozin 10 MG

Nutritional counselingBEHAVIORAL

Sponsors & collaborators

The University of Texas Health Science Center at San Antoniolead sponsor

National Institute on Aging (NIA)collaborator

Mapped research locations

San AntonioTexas, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04401904 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.